Medical News

RSS

GAO report details administration fund-raising efforts to boost health law

The investigation examined the campaign by federal officials to raise money to spur health insurance enrollment, according to The New York Times.

22 Apr 2014

FDA approves molecularly targeted drug as second-line treatment for advanced stomach cancer

Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration approved a molecularly targeted drug as second-line treatment in advanced stomach cancer that has progressed after standard chemotherapy has failed.

22 Apr 2014

New approach may help reduce use of antipsychotics and other psychiatric drugs in dementia patients

A new approach to handling agitation, aggression and other unwanted behaviors by people with dementia may help reduce the use of antipsychotics and other psychiatric drugs in this population, and make life easier for them and their caregivers, a team of experts says.

22 Apr 2014

Study outlines how regulations on alcohol, tobacco may provide guidance to consequences of legalizing marijuana

As U.S. policymakers consider ways to ease prohibitions on marijuana, the public health approaches used to regulate alcohol and tobacco over the past century may provide valuable lessons, according to new RAND Corporation research.

22 Apr 2014

Scientists receive federal grant to track how multi-walled carbon nanotubes interact with human cells

Scientists at The University of Texas at Dallas have received a federal grant to investigate how tiny carbon structures used in the manufacture of many everyday products might affect human health.

22 Apr 2014

Researchers develop simple assay that reveals evolutionary relationships among various tumor sites within patient

The process of metastasis - a tumor's ability to spread to other parts of the body - is still poorly understood. It is not easy to determine whether metastasis began early or late in the development of the primary tumor or whether individual metastatic sites were seeded directly from the original tumor or from an intermediate site.

22 Apr 2014

Small gene embedded in large gene contributes to development of acute myeloid leukemia

A small gene that is embedded in a larger, well-known gene is the true leukemia-promoting force usually attributed to the larger gene, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

22 Apr 2014

Global Generic Drugs market to grow at 11.02% CAGR over 2013-2018

Global Information Inc. announces the addition of a new market research report "Global Generic Drugs Market 2014-2018" at GIIResearch.com

21 Apr 2014

Doctors still make good money

An annual survey shows that doctors, on average, still make at least three times the annual median household income. Media outlets also describe other trends, including the return of house calls, often as part of hospital palliative care programs, the use of scribes to help with digital records, rushed doctors' visits and a study finding that free drug samples influence doctors' prescribing practices.

21 Apr 2014

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).

21 Apr 2014

New Aspen Dental office opens in Pickerington, OH

A new Aspen Dental office is opening in Pickerington, OH on Thursday, April 17. Located at 10705 Blacklick Eastern Rd 100, the conveniently located practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

21 Apr 2014

FDA approves Cochlear's Aqua+ accessory for cochlear implant recipients

Cochlear Limited, the global leader in implantable hearing solutions, announced that the US Food and Drug Administration has approved the Aqua+ accessory, the only waterproof behind-the-ear solution for cochlear implant recipients on the market today.

21 Apr 2014

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

21 Apr 2014

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced the publication of an overview of lysosomal acid lipase deficiency (LAL Deficiency) in the online version and an upcoming print edition of Atherosclerosis, the official journal of the European Atherosclerosis Society.

21 Apr 2014

Study points to new therapeutic strategy for treating depression

A new study points to a conceptually novel therapeutic strategy for treating depression. Instead of dampening neuron firing found with stress-induced depression, researchers demonstrated for the first time that further activating these neurons opens a new avenue to mimic and promote natural resilience.

21 Apr 2014

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR).

21 Apr 2014

FDA grants Orphan Drug Designation to Emergent BioSolutions' BioThrax for PEP of anthrax disease

Emergent BioSolutions Inc. announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to BioThrax (Anthrax Vaccine Adsorbed) for post-exposure prophylaxis (PEP) of anthrax disease resulting from suspected or confirmed exposure to Bacillus anthracis.

21 Apr 2014

MEDNAX acquires Fredericksburg Anesthesia Associates

MEDNAX, Inc., today announced the acquisition of Fredericksburg Anesthesia Associates, Inc., a private practice physician group based in Fredericksburg, Va. The practice will become part of MEDNAX's American Anesthesiology division and is the third Virginia-based anesthesia practice to join the division.

21 Apr 2014

First Edition: April 21, 2014

Today's early morning highlights from the major news organizations, including a GAO report on how the Obama administration raised money from outside groups to promote the health law.

21 Apr 2014

Sarepta Therapeutics plans to submit eteplirsen NDA for treatment of Duchenne muscular dystrophy

Sarepta Therapeutics, Inc., a developer of innovative RNA-based therapeutics, today announced it plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration by the end of 2014 for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD).

21 Apr 2014

Medical News

GAO report details administration fund-raising efforts to boost health law

FDA approves molecularly targeted drug as second-line treatment for advanced stomach cancer

New approach may help reduce use of antipsychotics and other psychiatric drugs in dementia patients

Study outlines how regulations on alcohol, tobacco may provide guidance to consequences of legalizing marijuana

Scientists receive federal grant to track how multi-walled carbon nanotubes interact with human cells

Researchers develop simple assay that reveals evolutionary relationships among various tumor sites within patient

Small gene embedded in large gene contributes to development of acute myeloid leukemia

Global Generic Drugs market to grow at 11.02% CAGR over 2013-2018

Doctors still make good money

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

New Aspen Dental office opens in Pickerington, OH

FDA approves Cochlear's Aqua+ accessory for cochlear implant recipients

New report analyzes Mobile Medical Apps market worldwide

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Study points to new therapeutic strategy for treating depression

Can-Fite BioPharma signs agreement with Smart Assays to develop A3AR predictive biomarker kit

FDA grants Orphan Drug Designation to Emergent BioSolutions' BioThrax for PEP of anthrax disease

MEDNAX acquires Fredericksburg Anesthesia Associates

First Edition: April 21, 2014

Sarepta Therapeutics plans to submit eteplirsen NDA for treatment of Duchenne muscular dystrophy

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News